世界の血漿分画装置市場2022年:市場規模予測(~2028年)

■ 英語タイトル:Global Blood Plasma Fractionation Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR22NO17232)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR22NO17232
■ 発行日:2022年11月(※2025年版があります。お問い合わせください。)
■ 調査対象地域:グローバル
■ 産業分野:医療機器
■ ページ数:102
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の血漿分画装置市場2022年:市場規模予測(~2028年)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

血漿分画装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の血漿分画装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

血漿分画装置市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・アルブミン、免疫グロブリン、凝固因子

用途別セグメントは次のように区分されます。
・免疫、治療、手術

世界の血漿分画装置市場の主要な市場プレーヤーは以下のとおりです。
・GE Healthcare、Pall Corporation、Baxter、CSL、Grifols、Octapharma、BPL、Kedrion、Mitsubishi Tanabe、CBOP、RAAS、Hualan Bio

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、血漿分画装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な血漿分画装置メーカーの企業概要、2019年~2022年までの血漿分画装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な血漿分画装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別血漿分画装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの血漿分画装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での血漿分画装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および血漿分画装置の産業チェーンを掲載しています。
・第13、14、15章では、血漿分画装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 血漿分画装置の概要
- 種類別分析(2017年vs2021年vs2028年):アルブミン、免疫グロブリン、凝固因子
- 用途別分析(2017年vs2021年vs2028年):免疫、治療、手術
- 世界の血漿分画装置市場規模・予測
- 世界の血漿分画装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- GE Healthcare、Pall Corporation、Baxter、CSL、Grifols、Octapharma、BPL、Kedrion、Mitsubishi Tanabe、CBOP、RAAS、Hualan Bio
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:アルブミン、免疫グロブリン、凝固因子
・用途別分析2017年-2028年:免疫、治療、手術
・血漿分画装置の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・血漿分画装置のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・血漿分画装置のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・血漿分画装置の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・血漿分画装置の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Blood Plasma Fractionation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Blood Plasma Fractionation market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunity accounting for % of the Blood Plasma Fractionation global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Albumin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Blood Plasma Fractionation include GE Healthcare, Pall Corporation, Baxter, CSL, and Grifols, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Blood Plasma Fractionation market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Albumin
Immune Globulin
Coagulation Factor
Market segment by Application can be divided into
Immunity
Therapy
Surgery
The key market players for global Blood Plasma Fractionation market are listed below:
GE Healthcare
Pall Corporation
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Plasma Fractionation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Blood Plasma Fractionation, with price, sales, revenue and global market share of Blood Plasma Fractionation from 2019 to 2022.
Chapter 3, the Blood Plasma Fractionation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Plasma Fractionation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Blood Plasma Fractionation market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Plasma Fractionation.
Chapter 13, 14, and 15, to describe Blood Plasma Fractionation sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次(コンテンツ)***

1 Market Overview
1.1 Blood Plasma Fractionation Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blood Plasma Fractionation Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.3 Market Analysis by Application
1.3.1 Overview: Global Blood Plasma Fractionation Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunity
1.3.3 Therapy
1.3.4 Surgery
1.4 Global Blood Plasma Fractionation Market Size & Forecast
1.4.1 Global Blood Plasma Fractionation Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Blood Plasma Fractionation Sales in Volume (2017-2028)
1.4.3 Global Blood Plasma Fractionation Price (2017-2028)
1.5 Global Blood Plasma Fractionation Production Capacity Analysis
1.5.1 Global Blood Plasma Fractionation Total Production Capacity (2017-2028)
1.5.2 Global Blood Plasma Fractionation Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Blood Plasma Fractionation Market Drivers
1.6.2 Blood Plasma Fractionation Market Restraints
1.6.3 Blood Plasma Fractionation Trends Analysis
2 Manufacturers Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Blood Plasma Fractionation Product and Services
2.1.4 GE Healthcare Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pall Corporation
2.2.1 Pall Corporation Details
2.2.2 Pall Corporation Major Business
2.2.3 Pall Corporation Blood Plasma Fractionation Product and Services
2.2.4 Pall Corporation Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Baxter
2.3.1 Baxter Details
2.3.2 Baxter Major Business
2.3.3 Baxter Blood Plasma Fractionation Product and Services
2.3.4 Baxter Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Blood Plasma Fractionation Product and Services
2.4.4 CSL Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Blood Plasma Fractionation Product and Services
2.5.4 Grifols Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Octapharma
2.6.1 Octapharma Details
2.6.2 Octapharma Major Business
2.6.3 Octapharma Blood Plasma Fractionation Product and Services
2.6.4 Octapharma Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 BPL
2.7.1 BPL Details
2.7.2 BPL Major Business
2.7.3 BPL Blood Plasma Fractionation Product and Services
2.7.4 BPL Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Kedrion
2.8.1 Kedrion Details
2.8.2 Kedrion Major Business
2.8.3 Kedrion Blood Plasma Fractionation Product and Services
2.8.4 Kedrion Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mitsubishi Tanabe
2.9.1 Mitsubishi Tanabe Details
2.9.2 Mitsubishi Tanabe Major Business
2.9.3 Mitsubishi Tanabe Blood Plasma Fractionation Product and Services
2.9.4 Mitsubishi Tanabe Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBOP
2.10.1 CBOP Details
2.10.2 CBOP Major Business
2.10.3 CBOP Blood Plasma Fractionation Product and Services
2.10.4 CBOP Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 RAAS
2.11.1 RAAS Details
2.11.2 RAAS Major Business
2.11.3 RAAS Blood Plasma Fractionation Product and Services
2.11.4 RAAS Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Hualan Bio
2.12.1 Hualan Bio Details
2.12.2 Hualan Bio Major Business
2.12.3 Hualan Bio Blood Plasma Fractionation Product and Services
2.12.4 Hualan Bio Blood Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Blood Plasma Fractionation Breakdown Data by Manufacturer
3.1 Global Blood Plasma Fractionation Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Blood Plasma Fractionation Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Blood Plasma Fractionation
3.4 Market Concentration Rate
3.4.1 Top 3 Blood Plasma Fractionation Manufacturer Market Share in 2021
3.4.2 Top 6 Blood Plasma Fractionation Manufacturer Market Share in 2021
3.5 Global Blood Plasma Fractionation Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Blood Plasma Fractionation Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Blood Plasma Fractionation Market Size by Region
4.1.1 Global Blood Plasma Fractionation Sales in Volume by Region (2017-2028)
4.1.2 Global Blood Plasma Fractionation Revenue by Region (2017-2028)
4.2 North America Blood Plasma Fractionation Revenue (2017-2028)
4.3 Europe Blood Plasma Fractionation Revenue (2017-2028)
4.4 Asia-Pacific Blood Plasma Fractionation Revenue (2017-2028)
4.5 South America Blood Plasma Fractionation Revenue (2017-2028)
4.6 Middle East and Africa Blood Plasma Fractionation Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Blood Plasma Fractionation Sales in Volume by Type (2017-2028)
5.2 Global Blood Plasma Fractionation Revenue by Type (2017-2028)
5.3 Global Blood Plasma Fractionation Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Blood Plasma Fractionation Sales in Volume by Application (2017-2028)
6.2 Global Blood Plasma Fractionation Revenue by Application (2017-2028)
6.3 Global Blood Plasma Fractionation Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Blood Plasma Fractionation Sales by Type (2017-2028)
7.2 North America Blood Plasma Fractionation Sales by Application (2017-2028)
7.3 North America Blood Plasma Fractionation Market Size by Country
7.3.1 North America Blood Plasma Fractionation Sales in Volume by Country (2017-2028)
7.3.2 North America Blood Plasma Fractionation Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Blood Plasma Fractionation Sales by Type (2017-2028)
8.2 Europe Blood Plasma Fractionation Sales by Application (2017-2028)
8.3 Europe Blood Plasma Fractionation Market Size by Country
8.3.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2017-2028)
8.3.2 Europe Blood Plasma Fractionation Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Blood Plasma Fractionation Sales by Type (2017-2028)
9.2 Asia-Pacific Blood Plasma Fractionation Sales by Application (2017-2028)
9.3 Asia-Pacific Blood Plasma Fractionation Market Size by Region
9.3.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Blood Plasma Fractionation Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Blood Plasma Fractionation Sales by Type (2017-2028)
10.2 South America Blood Plasma Fractionation Sales by Application (2017-2028)
10.3 South America Blood Plasma Fractionation Market Size by Country
10.3.1 South America Blood Plasma Fractionation Sales in Volume by Country (2017-2028)
10.3.2 South America Blood Plasma Fractionation Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Blood Plasma Fractionation Sales by Type (2017-2028)
11.2 Middle East & Africa Blood Plasma Fractionation Sales by Application (2017-2028)
11.3 Middle East & Africa Blood Plasma Fractionation Market Size by Country
11.3.1 Middle East & Africa Blood Plasma Fractionation Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Blood Plasma Fractionation Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Blood Plasma Fractionation and Key Manufacturers
12.2 Manufacturing Costs Percentage of Blood Plasma Fractionation
12.3 Blood Plasma Fractionation Production Process
12.4 Blood Plasma Fractionation Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Blood Plasma Fractionation Typical Distributors
13.3 Blood Plasma Fractionation Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Blood Plasma Fractionation Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Blood Plasma Fractionation Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. GE Healthcare Major Business
Table 5. GE Healthcare Blood Plasma Fractionation Product and Services
Table 6. GE Healthcare Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pall Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Pall Corporation Major Business
Table 9. Pall Corporation Blood Plasma Fractionation Product and Services
Table 10. Pall Corporation Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Baxter Basic Information, Manufacturing Base and Competitors
Table 12. Baxter Major Business
Table 13. Baxter Blood Plasma Fractionation Product and Services
Table 14. Baxter Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CSL Basic Information, Manufacturing Base and Competitors
Table 16. CSL Major Business
Table 17. CSL Blood Plasma Fractionation Product and Services
Table 18. CSL Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Grifols Basic Information, Manufacturing Base and Competitors
Table 20. Grifols Major Business
Table 21. Grifols Blood Plasma Fractionation Product and Services
Table 22. Grifols Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Octapharma Basic Information, Manufacturing Base and Competitors
Table 24. Octapharma Major Business
Table 25. Octapharma Blood Plasma Fractionation Product and Services
Table 26. Octapharma Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. BPL Basic Information, Manufacturing Base and Competitors
Table 28. BPL Major Business
Table 29. BPL Blood Plasma Fractionation Product and Services
Table 30. BPL Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Kedrion Basic Information, Manufacturing Base and Competitors
Table 32. Kedrion Major Business
Table 33. Kedrion Blood Plasma Fractionation Product and Services
Table 34. Kedrion Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mitsubishi Tanabe Basic Information, Manufacturing Base and Competitors
Table 36. Mitsubishi Tanabe Major Business
Table 37. Mitsubishi Tanabe Blood Plasma Fractionation Product and Services
Table 38. Mitsubishi Tanabe Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CBOP Basic Information, Manufacturing Base and Competitors
Table 40. CBOP Major Business
Table 41. CBOP Blood Plasma Fractionation Product and Services
Table 42. CBOP Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Blood Plasma Fractionation Product and Services
Table 46. RAAS Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 48. Hualan Bio Major Business
Table 49. Hualan Bio Blood Plasma Fractionation Product and Services
Table 50. Hualan Bio Blood Plasma Fractionation Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Blood Plasma Fractionation Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Blood Plasma Fractionation Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Blood Plasma Fractionation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Blood Plasma Fractionation Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Blood Plasma Fractionation Production Site of Key Manufacturer
Table 56. Blood Plasma Fractionation New Entrant and Capacity Expansion Plans
Table 57. Blood Plasma Fractionation Mergers & Acquisitions in the Past Five Years
Table 58. Global Blood Plasma Fractionation Sales by Region (2017-2022) & (K Units)
Table 59. Global Blood Plasma Fractionation Sales by Region (2023-2028) & (K Units)
Table 60. Global Blood Plasma Fractionation Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Blood Plasma Fractionation Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Blood Plasma Fractionation Sales by Type (2017-2022) & (K Units)
Table 63. Global Blood Plasma Fractionation Sales by Type (2023-2028) & (K Units)
Table 64. Global Blood Plasma Fractionation Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Blood Plasma Fractionation Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Blood Plasma Fractionation Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Blood Plasma Fractionation Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Blood Plasma Fractionation Sales by Application (2017-2022) & (K Units)
Table 69. Global Blood Plasma Fractionation Sales by Application (2023-2028) & (K Units)
Table 70. Global Blood Plasma Fractionation Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Blood Plasma Fractionation Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Blood Plasma Fractionation Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Blood Plasma Fractionation Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Blood Plasma Fractionation Sales by Country (2017-2022) & (K Units)
Table 75. North America Blood Plasma Fractionation Sales by Country (2023-2028) & (K Units)
Table 76. North America Blood Plasma Fractionation Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Blood Plasma Fractionation Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Blood Plasma Fractionation Sales by Type (2017-2022) & (K Units)
Table 79. North America Blood Plasma Fractionation Sales by Type (2023-2028) & (K Units)
Table 80. North America Blood Plasma Fractionation Sales by Application (2017-2022) & (K Units)
Table 81. North America Blood Plasma Fractionation Sales by Application (2023-2028) & (K Units)
Table 82. Europe Blood Plasma Fractionation Sales by Country (2017-2022) & (K Units)
Table 83. Europe Blood Plasma Fractionation Sales by Country (2023-2028) & (K Units)
Table 84. Europe Blood Plasma Fractionation Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Blood Plasma Fractionation Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Blood Plasma Fractionation Sales by Type (2017-2022) & (K Units)
Table 87. Europe Blood Plasma Fractionation Sales by Type (2023-2028) & (K Units)
Table 88. Europe Blood Plasma Fractionation Sales by Application (2017-2022) & (K Units)
Table 89. Europe Blood Plasma Fractionation Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Blood Plasma Fractionation Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Blood Plasma Fractionation Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Blood Plasma Fractionation Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Blood Plasma Fractionation Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Blood Plasma Fractionation Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Blood Plasma Fractionation Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Blood Plasma Fractionation Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Blood Plasma Fractionation Sales by Application (2023-2028) & (K Units)
Table 98. South America Blood Plasma Fractionation Sales by Country (2017-2022) & (K Units)
Table 99. South America Blood Plasma Fractionation Sales by Country (2023-2028) & (K Units)
Table 100. South America Blood Plasma Fractionation Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Blood Plasma Fractionation Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Blood Plasma Fractionation Sales by Type (2017-2022) & (K Units)
Table 103. South America Blood Plasma Fractionation Sales by Type (2023-2028) & (K Units)
Table 104. South America Blood Plasma Fractionation Sales by Application (2017-2022) & (K Units)
Table 105. South America Blood Plasma Fractionation Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Blood Plasma Fractionation Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Blood Plasma Fractionation Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Blood Plasma Fractionation Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Blood Plasma Fractionation Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Blood Plasma Fractionation Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Blood Plasma Fractionation Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Blood Plasma Fractionation Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Blood Plasma Fractionation Sales by Application (2023-2028) & (K Units)
Table 114. Blood Plasma Fractionation Raw Material
Table 115. Key Manufacturers of Blood Plasma Fractionation Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Blood Plasma Fractionation Typical Distributors
Table 119. Blood Plasma Fractionation Typical Customers
List of Figures
Figure 1. Blood Plasma Fractionation Picture
Figure 2. Global Blood Plasma Fractionation Revenue Market Share by Type in 2021
Figure 3. Albumin
Figure 4. Immune Globulin
Figure 5. Coagulation Factor
Figure 6. Global Blood Plasma Fractionation Revenue Market Share by Application in 2021
Figure 7. Immunity
Figure 8. Therapy
Figure 9. Surgery
Figure 10. Global Blood Plasma Fractionation Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Blood Plasma Fractionation Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Blood Plasma Fractionation Sales (2017-2028) & (K Units)
Figure 13. Global Blood Plasma Fractionation Price (2017-2028) & (USD/Unit)
Figure 14. Global Blood Plasma Fractionation Production Capacity (2017-2028) & (K Units)
Figure 15. Global Blood Plasma Fractionation Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Blood Plasma Fractionation Market Drivers
Figure 17. Blood Plasma Fractionation Market Restraints
Figure 18. Blood Plasma Fractionation Market Trends
Figure 19. Global Blood Plasma Fractionation Sales Market Share by Manufacturer in 2021
Figure 20. Global Blood Plasma Fractionation Revenue Market Share by Manufacturer in 2021
Figure 21. Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Blood Plasma Fractionation Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Blood Plasma Fractionation Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Blood Plasma Fractionation Sales Market Share by Region (2017-2028)
Figure 25. Global Blood Plasma Fractionation Revenue Market Share by Region (2017-2028)
Figure 26. North America Blood Plasma Fractionation Revenue (2017-2028) & (USD Million)
Figure 27. Europe Blood Plasma Fractionation Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Blood Plasma Fractionation Revenue (2017-2028) & (USD Million)
Figure 29. South America Blood Plasma Fractionation Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Blood Plasma Fractionation Revenue (2017-2028) & (USD Million)
Figure 31. Global Blood Plasma Fractionation Sales Market Share by Type (2017-2028)
Figure 32. Global Blood Plasma Fractionation Revenue Market Share by Type (2017-2028)
Figure 33. Global Blood Plasma Fractionation Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Blood Plasma Fractionation Sales Market Share by Application (2017-2028)
Figure 35. Global Blood Plasma Fractionation Revenue Market Share by Application (2017-2028)
Figure 36. Global Blood Plasma Fractionation Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Blood Plasma Fractionation Sales Market Share by Type (2017-2028)
Figure 38. North America Blood Plasma Fractionation Sales Market Share by Application (2017-2028)
Figure 39. North America Blood Plasma Fractionation Sales Market Share by Country (2017-2028)
Figure 40. North America Blood Plasma Fractionation Revenue Market Share by Country (2017-2028)
Figure 41. United States Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Blood Plasma Fractionation Sales Market Share by Type (2017-2028)
Figure 45. Europe Blood Plasma Fractionation Sales Market Share by Application (2017-2028)
Figure 46. Europe Blood Plasma Fractionation Sales Market Share by Country (2017-2028)
Figure 47. Europe Blood Plasma Fractionation Revenue Market Share by Country (2017-2028)
Figure 48. Germany Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Blood Plasma Fractionation Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Blood Plasma Fractionation Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Blood Plasma Fractionation Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Blood Plasma Fractionation Revenue Market Share by Region (2017-2028)
Figure 57. China Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Blood Plasma Fractionation Sales Market Share by Type (2017-2028)
Figure 64. South America Blood Plasma Fractionation Sales Market Share by Application (2017-2028)
Figure 65. South America Blood Plasma Fractionation Sales Market Share by Country (2017-2028)
Figure 66. South America Blood Plasma Fractionation Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Blood Plasma Fractionation Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Blood Plasma Fractionation Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Blood Plasma Fractionation Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Blood Plasma Fractionation Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Blood Plasma Fractionation Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Blood Plasma Fractionation in 2021
Figure 78. Manufacturing Process Analysis of Blood Plasma Fractionation
Figure 79. Blood Plasma Fractionation Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR22NO17232 )"世界の血漿分画装置市場2022年:市場規模予測(~2028年)" (英文:Global Blood Plasma Fractionation Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。